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Abstract
Background: Intraoperative neurophysiology, high magnification microscopes, 
and ultrasonic aspirators are considered essential aid for the safe resection of 
intramedullary spinal cord tumors (IMSCTs). Most centers in developing countries 
such as Pakistan still lack these facilities. The purpose of this study was to review 
the management of IMSCTs at our hospital and to determine factors associated 
with the outcomes of surgery.
Methods: This was a retrospective review of medical records of adult patients 
undergoing surgery for IMSCT over 12 years. The institutional ethical review 
committee approved this study. Data were collected regarding demographics, 
clinical and radiological features, and surgical details. Modified McCormick Scale 
was used to grade patients’ neurological status at admission, discharge, and 
follow‑up. Statistical analysis was performed using the Statistical Package for 
Social Sciences version 22.
Results: Forty three cases were reviewed. Mean age was 33.8 ± 15.1 years 
whereas median follow‑up was 5 months (range: 0.25–96 months). Most 
patients had ependymoma (n = 16; 73%). Cervical region was the most 
commonly involved (n = 15; 34.9%). Gross total resection (GTR) was achieved in 
30 cases (69.8%). The preoperative McCormick grade was significantly associated 
with follow‑up McCormick grade (P value = 0.002). Eight patients (18.6%) underwent 
intraoperative electrophysiological monitoring, out of which GTR was achieved in 
all cases, and none had disease progression or recurrence. Ten patients received 
postoperative radiotherapy. Thirty five patients (81.4%) had progression free 
survival at last follow‑up.
Conclusions: We achieved a GTR rate of 68.9% for IMSCTs with limited resources. 
In few cases, where intraoperative electrophysiology was used, the rate of GTR was 
100%. Preoperative neurological status was associated with better postoperative 
McCormick score.
Key Words: Intramedullary spinal cord tumor, modified McCormick scale, 
spinal cord
How to cite this article: Bakhshi SK, Waqas M, Shakaib B, Enam SA. Management and outcomes of intramedullary spinal cord tumors: A single center experience from a 
developing country. Surg Neurol Int 2016;7:S617-22.
http://surgicalneurologyint.com/Management-and-outcomes-of-intramedullary-spinal-cord-tumors:-A-single-center-experience-from-a-developing-country/
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and 
build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com






Management and outcomes of intramedullary spinal cord tumors: 
A single center experience from a developing country
Saqib K. Bakhshi, Muhammad Waqas, Baila Shakaib, Syed A. Enam
Department of Surgery, Section of Neurosurgery, Aga Khan University Hospital, Karachi, Pakistan
E‑mail: Saqib K. Bakhshi ‑ saqib_dmc@hotmail.com; Muhammad Waqas ‑ shaiq_waqas@hotmail.com; Baila Shakaib ‑ bailashakaib@gmail.com; 
*Syed A. Enam ‑ ather.enam@aku.edu 
*Corresponding author
Received: 01 July 16  Accepted: 13 July 16  Published: 01 September 16
S618
SNI: Neuro-Oncology 2016,  Vol 7, Suppl 23 - A Supplement to Surgical Neurology International 
INTRODUCTION
Intramedullary spinal cord tumors (IMSCT) account for 
only 4–10% of all primary central nervous system (CNS) 
neoplastic lesions and 20% of all spinal cord tumors 
in adults.[8] Although uncommon, IMSCTs can cause 
disability and severely affect the quality of life.[8,11] 
Spinal ependymoma is the most frequently occurring 
IMSCT.[8,11] Magnetic resonance imaging (MRI) is 
the imaging modality of choice for the diagnosis and 
characterization of these lesions.[20]
According to previous studies regarding treatment options, 
early surgical excision, possibly gross total resection 
(GTR), improves functional outcomes.[11,16,18] Numerous 
authors have endorsed regular use of intraoperative 
electrophysiological monitoring (IOEM) including 
somatosensory‑evoked potentials (SSEP) and 
motor‑evoked potentials (MEP); however, there is 
insufficient evidence assessing their real impact on 
functional outcomes.[6,9,14,17]
There is scarcity of data on IMSCT from Pakistan[1] 
and other countries from South Asia, where performing 
maximum resection of tumor becomes even more 
challenging due to resource limitations. The purpose of 
this study was to review the presentation, management, 
and outcomes IMSCTs at our hospital during last 
12 years and to determine the factors associated with 
outcomes of surgery.
MATERIALS AND METHODS
This was a retrospective review. All patients who 
underwent surgery for IMSCT at our hospital between 
2003 and 2015 with complete records available, 
irrespective of age and gender, were included. The 
patients were identified by the Medical Records 
department of the hospital, which then retrieved their 
medical records. Ethical approval was obtained from 
the Ethical Review Committee at Aga Khan University 
Hospital, Karachi (3533‑Sur‑ERC‑15).
Data was collected according to a proforma. It consisted 
of different variables including demographics, clinical 
presentation of disease and management in the hospital, 
histopathological diagnosis, and postoperative course of 
the disease. This information was extracted by reviewing 
patients’ medical records. Patients with incomplete 
records were excluded from the study.
GTR was defined as the removal of >95% tumor tissue, 
which was either mentioned in operative notes or seen on 
postoperative MRI. Maximum safe resection (MSR) was 
defined as the removal of maximum volume of tissue, 
which could be safely removed. Biopsy was defined as 
the removal of only a small amount of tissue required for 
histological analysis.
Use of IOEM is not a standard practice at our hospital 
so it was utilized in some cases using SSEP. Tumor was 
histologically diagnosed and then graded according to the 
World Health Organization (WHO) classification at the 
histopathology department of our hospital. Progression 
free survival (PFS) was defined as no recurrence of 
disease after GTR and no increase in the size of residual 
disease after MSR or biopsy.
Modified McCormick Scale (MMS) was used for grading 
patients’ neurological status at admission, immediately 
after surgery and at last follow‑up [Table 1].[13]
Surgical technique for intramedullary spinal 
cord tumors
We perform the procedure in prone position under general 
anesthesia. For cervical surgeries, Mayfield clamp is used 
to fix the head in a flexed position. It is ensured that 
abdomen is free and all the pressure points are adequately 
padded. We confirm the level of surgery with the help of 
fluoroscope before starting incision and after exposure of 
laminae. For cases where intraoperative electrophysiology 
monitoring is planned, electrodes are placed after 
positioning. A midline posterior approach is used with 
subperiosteal dissection to expose laminae bilaterally. 
Facet joints are carefully preserved. Laminectomy is 
performed at the level of the tumor, ensuring that we 
have an adequate exposure of cranial and caudal limits 
of the tumor. In few cases, we have also performed 
laminoplasty without compromising exposure. After 
extradural hemostasis, a midline durotomy is performed 
using hook and knife. Posterior median sulcus is then 
identified and gently opened to access the tumor. We 
do not use coagulation and stay within the limits of the 
tumor performing internal debulking with the help of 
dissector and tumor forceps. After limited debulking, we 
dissect the tumor from margins and roll it inward.
Once the dissection is completed till the normal cord 
we complete the hemostasis. We use surgical (fibrillar 
and other) instead of cotton balls. Our use of cavitron 
ultrasonic surgical aspirator (CUSA) is very limited 
because of the high cost associated with its disposables. 
SSEP monitoring is not used consistently. Dura is closed 
in a watertight fashion using nonabsorbable suture. 
Valsalva maneuver is performed to look for any leak. 
Wound is then closed in layers.
Table 1: Modified McCormick scale
Grade Modified McCormick Scale
I Intact neurologically, normal ambulation, minimal dysesthesia
II Mild motor or sensory deficit, functional independence
III Moderate deficit, limitation of function, independent with 
external aid
IV Severe motor or sensory deficit, limited function, dependent
V Paraplegia or quadriplegia, even with flickering movement
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Statistical analysis
Statistical Analysis was done using Statistical Package 
for Social Sciences (SPSS Inc., Chicago, IL, USA. 
Version 22.0). Means and standard deviation were calculated 
for continuous data with normal distribution whereas 
median and interquartile range (IQR) were calculated for 
continuous data with skewed distribution. Percentages and 
proportions were calculated for categorical data. Fisher’s 
exact test was used to compare categorical data. Preoperative 
neurological status, tumor histology, extent of resection, 
and IOEM were correlated with postoperative neurological 
outcome. Kaplan–Meier graph was plotted to portray PFS.
RESULTS
Forty three patients were included in the study. Median 
age was 33.2 years, and the most common presenting 
complaint was back pain present in 24 patients (55.8%). 
The most common location was cervical spine (n = 15; 
34.9) Only 3 patients (7.0%) had single level disease 
and half of the patients had their disease involving 2 or 
3 spinal levels (n = 22; 51.1%). The highest numbers 
of disease levels involved were 7 present in 2 (4.7%) 
patients. The most common histological diagnosis 
was ependymoma. Patients’ demographics and clinical 
characteristics are shown in Table 2.
We performed GTR in 30 patients (69.8%). 
Intraoperative electrophysiological monitoring (IOEM) 
was used in 8 (18.6%) patients and GTR was achieved 
in all of them. Twenty nine (67.4%) patients had one 
or more postoperative MRI done. Ten patients (23.3%) 
received postoperative radiotherapy while none of the 
patients received postoperative chemotherapy.
Neurological status
Postoperatively, 15 patients (34.9%) showed improvement 
in their neurological function before discharge, 
10 (23.2%) had transient worsening of function, 
and 18 (41.9%) had no change. At last follow‑up, an 
improvement in neurological function was observed 
in 24 patients (55.8%), 15 (34.9%) maintained their 
preoperative function, and only 4 patients (9.3%) had 
persistently worsened neurological status. Graph 1 shows 
that better pre‑operative MMS grades that resulted in 
better neurological function postoperatively (P = <0.001) 
and at last follow‑up (P = 0.002) [Graph 1].
Graph 2 depicts change in neurological status at 
last follow‑up compared to the preoperative status, 
and the role of IOEM, which was not statistically 
significant (P = 0.456) [Graph 2].
Progression free survival
Eight patients (18.6%) had recurrence or progression 
of disease after surgery. Only 3% of all the patients who 
had GTR had disease progression, whereas 45% patients 
with MSR and all patients with biopsy had disease 
progression (P = 0.004). Thirty five patients (81.4%) 
had progression free survival at last follow‑up. Table 3 
shows some possible predictors of PFS.
Patients undergoing GTR had a significantly better 
survival as compared to those who underwent MSR 
or only biopsy on Kaplan–Meier log‑rank analysis 
Table 2: Demographics and clinical characteristics
Demographics and Clinical Characteristics






Diabetes mellitus n=2 (4.6%)
Ischemic heart disease n=1 (2.3%)
Benign prostatic hyperplasia n=1 (2.3%)
Length of hospital stay (Median) 7 days (IQR=4-10 days)
Follow-up time (Median) 5 months (IQR=2-15 months)
Most common presenting complaint Backache 







Operating time (Mean) 277.7±94.0 minutes











Gross total resection n=30 (69.8%)
Maximum safe resection n=11 (25.6%)
Biopsy n=2 (4.7%)
Table 3: Predictors of progression free survival




Size of Lesion (>3 levels) 0.050
IOEM 0.679
GTR 0.002
Low grade lesion (Grade I/II) 0.011
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(P = <0.001), as shown in Figure 1. Similarly patients 
who had lower histopathological grade (grade I/II) had a 
better survival compared to those who had higher grades 
of lesion (grade III/IV), as shown in Figure 2.
DISCUSSION
Lesions involving the spinal cord have always tested 
surgeons’ skill. Figure 3 (a‑c) shows MRI scans of a 
20‑year‑old girl who presented with progressive weakness 
in all four limbs, more on the right side, for 2 years. 
Her preoperative MMS was 3. She underwent cervical 
laminectomy and gross total excision of the lesion 5 years 
back. Her immediate postoperative MMS was 2, and at 
last follow‑up after 4 years, it was 1. Last follow‑up scans 
done 4 years after surgery are shown in Figure 4 (a‑c).
Last few years have seen major advances toward better 
treatment of IMSCTs owing to developments in imaging 
techniques and surgical procedures.[9,11,12] We studied 
patients with IMSCT who were surgically treated at 
our hospital during last the 12 years; our sample of 
43 patients is slightly less but comparable to most other 
studies, although few studies with larger sample size have 
been reported.[15,18] Our median follow‑up of 5 months is, 
however, less than previous studies.[15,18]
Surgeons operating on IMSCTs are faced with the 
predicament of attempting radical excision, and yet, preserve 
adequate neural tissue. In a retrospective review conducted 
in 2005 involving 78 patients, Sandalcioglu et al.[18] reported 
that they achieved GTR in 83.3% patients and cited 
preoperative neurological status as the most important 
predicting factor of functional outcome. Similar findings 
were quoted by Kumar et al.[10] in their study on 43 patients. 
In another series of 70 cases, Bostrom et al.[2] also reported 
complete removal in 64.3% cases and stated early GTR of 
spinal ependymoma to be associated with better outcomes, 
limiting role of MSR, or biopsy with adjuvant therapy for 
high grade astrocytoma. We achieved GTR in 69.7% patients 
and have also found statistically significant relationship 
between preoperative and last follow‑up neurological 
function. Because of less number of cases, subgroup analysis 




























Graph 1: McCormick grades on pre-operative, post-operative and 

















All patients Patients with IOEM Patients without IOEM
Improvement in Neurological Status Deterioration in Neurological Status
No Change
Graph 2: Change in neurological status at last follow-up and 
intraoperative electrophysiological monitoring
Figure 1: Kaplan–Meier analysis for progression free survival with 
gross resection rate, maximum safe resection, and biopsy
Figure 2: Kaplan–Meier analysis for progression free survival with 
regards to grade of lesion
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In another study conducted in 2009, Matsuyama et al.[12] 
included 106 patients with a wide age range of 6–75 years. 
Their mean follow‑up period was 7.3 years. They reported 
preoperative ambulatory status and GTR to be associated 
with better neurological prognosis; however, they observed 
postoperative neurological worsening in 31.5% patients. 
This was higher as compared to our observation of 
transient postoperative neurological deficits in 23.2% 
patients. Only 11.6% of our patients developed permanent 
neurological deficits after surgery at last follow‑up which 
is better than most than other studies that observed 
permanent deterioration in 11.6–34.6% patients.[2,10,12]
Management of tumors is always aimed at improving 
PFS. We have reported recurrence or disease 
progression in 18.6% patients, which is consistent 
with the recurrence rates of 9–22% in the current 
published literature.[2,10,18] Earlier studies have reported 
high grade astrocytoma and malignant IMSCT 
along with extent of resection to be associated with 
increased risk of recurrence.[4,5] In our study, more 
than half of the recurrences/disease progressions were 
seen in astrocytoma, however, it was not statistically 
significant (P = 0.308). We reported GTR and low 
grade of lesion to be significant predictors of PFS, 
which is in agreement with previous studies.[10,18]
There is controversy in existing literature regarding 
the role of adjuvant radiotherapy and chemotherapy 
for IMSCT, with some latest studies limiting its role 
to tumors which are not completely resectable.[3,7,18,19] 
Approximately a quarter of our patients received adjuvant 
radiotherapy and none received chemotherapy, however, 
we did not find any significant impact of radiation 
therapy on PFS or neurological outcomes.
The use of intraoperative electrophysiology techniques 
including SSEP and/or MEP has been advocated to help 
maintain patient’s neurological function after surgery, 
which along with excision of entire tumor is the aim in 
most procedures. In our study, IOEM was used in only 
8 (18.6%) patients, 3 of which had temporary and 1 
had permanent postoperative worsening of neurological 
function. We did not observe any significant association 
of IOEM with extent of surgical resection or preservation 
of functional status. This is in contrast to studies at 
other centers which used this modality more often and 
attributed improved function due to its use improved 
outcomes.[6,9,12,17] Our different findings may be due to 
less often use of this modality and technical difficulties.
We included patients operated by multiple surgeons at a 
single center and the follow‑up period was small, which 
are important limitations of this study. Another important 
feature is the impact of different anatomical levels of 
disease on functional status, which was not found to be 
statistically significant in our study, which again might be 
due to the smaller number of study participants. However, 
considering the rarity of these tumors and insufficient 
data from developing countries, our study highlights 
important aspects in the presentation, management and 
outcomes of IMSCTs in our region.
CONCLUSION
We have achieved a GTR rate of 68.9% for IMSCTs 
using limited technological assistance. In few cases, 
Figure 3: (a) MRI cervical spine T2 weighted sagittal image showing 
hyper-intense contrast enhancing lesion at C5-C7. (b) Magnetic 
resonance imaging (MRI) cervical spine T1 weighted sagittal image 
showing hyperintense lesion at C5-C7. (c) MRI T1 weighted axial 
image showing large circumscribed hyper-intense lesion pushing 
spinal cord to left side
a b
c
Figure 4: (a) Post-operative MRI cervical spine T2 weighted sagittal 
image showing thinning of spinal cord at C6. (b) Post-operative 
MRI T2 weighted axial image showing thin spinal cord surrounded 
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where intraoperative electrophysiology was used, the rate 
of GTR was 100%. Preoperative neurological status was 
associated with better postoperative McCormick score.
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